Health Catalyst (HCAT) Upgraded by Zacks Investment Research to Buy

Health Catalyst} stock has undergone multiple analysts rating changes in the recent past.  Health Catalyst Upgraded by Zacks Investment Research on 10-11-21. In a note to investors, the firm issued a new rating of Buy. The analysts previously had rating of Hold.

View More Health Catalyst (HCAT) Upgraded by Zacks Investment Research to Buy